As the coronavirus S glycoprotein is located outside of the viral particle and mediates the viral entry into the host epithelial cells, it is undoubtedly the main target of neutralizing antibodies (NAbs) upon infection, making it the most important therapeutic target and essential in vaccine design. Here, ART4 is linked to infection.